Fig. 1

Comparison of ITN usage, ITN access, proportion of children seeking treatment and DTP3 coverage. The colour gradient represents P. falciparum prevalence in children aged 12–59 months. The countries shown are: AO—Angola, BF—Burkina Faso, BJ—Benin, BU—Burundi, CD—Democratic Republic of Congo, CI—Cote d’Ivoire, CM—Cameroon, GH—Ghana, GN—Guinea, KE—Kenya, LB—Liberia, ML—Mali, MW—Malawi, MZ—Mozambique, NG—Nigeria, SL—Sierra Leone, TG—Togo, TZ—Tanzania, UG—Uganda and ZM—Zambia. A–C show ITN usage, ITN access and the proportion of children seeking treatment versus DTP3 coverage, respectively. D Difference in DTP3 coverage and ITN usage ranked in order of increasing difference with the bars coloured by P. falciparum prevalence. E Difference in DTP3 coverage and ITN access ranked in order of increasing difference with the bars coloured by P. falciparum prevalence. F Difference in DTP3 coverage and proportion of children seeking treatment with the bars coloured by P. falciparum prevalence. In Figs D–F, positive bars indicate where DTP3 coverage is higher than the intervention it is being compared against